+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Biophotonics Market Research and Forecast, 2019-2025

  • ID: 4753702
  • Report
  • February 2019
  • Region: Global
  • Orion Market Research Private Limited
until Mar 31st 2020
1 of 3


  • Andor Technology Ltd.
  • Bio-Rad Laboratories Inc.
  • Carl Zeiss Meditec AG
  • DYSIS Medical Ltd.
  • Newport Corp.
  • Olympus Corp.
  • MORE
Global Biophotonics Market Size, Share & Trends Analysis Report by Technology (In-Vitro, and In-Vivo), by Application (Microscopy, Biosensors, Imaging and Other Applications), By End-Use (Medical Diagnostic, Medical Therapeutic, Medical Monitoring, and Other End-Use), and Forecasts, 2019 - 2025.

Biophotonics is a technology which harnesses light-based technologies in life sciences, medicines, and related fields. Non-invasiveness and reduced time of diagnostic procedures coupled with more focused and precise therapeutic are some of the main advantages that biophotonics offer over the conventional clinical technologies. Global biophotonics market is expected to witness impressive growth over the forecast period. Major factors that are prevailing the market growth are surging geriatric population globally, increasing demand for accurate early diagnosis of diseases, and advances in optical technologies. Besides, biophotonics technology also caters to a wide range of non-medical applications which are expected to offer several growth avenues over the forecast period.

Surging geriatric population base is primarily fuelling the growth of the market. Aging is associated with the damage to the cells at a biological level. This factor weakens the immune system over time and ends the capacity of the body to repair itself, resulting in an increased risk of developing different diseases. Standards of medical care have been improving for the last 60 or so years throughout the globe. This has led to an increase in life expectancy of the population causing a surge in the size of the geriatric subgroup. According to data from the United Nations, a number of people globally with age 80 and above in 2017 was 137 million. This number is projected to reach 425 million by 2050, that is, it is estimated to get tripled of the present value. Moreover, it is expected to cross 909 million by 2100, that is increasing seven times of the value in 2017.

In addition, North America is expected to dominate the market over the forecast period owing to the emergence of nanotechnology in the region. Moreover, significant US government’s initiatives and well-developed healthcare infrastructure of the region is further supporting the market growth. Additionally, the Asia-Pacific region is likely to register the highest growth due to the rapidly emerging healthcare sector in the emerging economies of the region such as China, India, South Korea, and Indonesia.

Global biophotonics market consists of several small to large players which are scattered across the globe. Players such as Agilent Technologies, Inc., Carl Zeiss Meditec AG, Biophotonic Solutions, Inc., and Becton, Dickinson & Co., adopt various strategies to stay competitive in the market and give the edge to edge competition to their rivals. Strategies such as mergers & acquisition, product launch, geographical expansion, and partnership & collaboration are majorly adopted by these market players. For instance, in September 2017, Olympus Corp. has launched the ORBEYE surgical microscope with 4K 3D capabilities. This microscope has several enhanced features such as high-resolution digital images and stereoscopic visual field which supports precision surgery.

Research Methodology

The market study of the global biophotonics market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the publisher's.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the WHO, the United Nations, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.
The report is intended for research organizations, biotechnology companies, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

Global Biophotonics market is segmented on the basis of regional outlook and following segments:
1. Global Biophotonics Market Research and Analysis by Technology
2. Global Biophotonics Market Research and Analysis by Application
3. Global Biophotonics Market Research and Analysis by End-Use
4. Global Biophotonics Market Research and Analysis by Geography

The Report Covers:
  • Comprehensive research methodology of the global biophotonics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global biophotonics market.
  • Insights about market determinants which are stimulating the global biophotonics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • Andor Technology Ltd.
  • Bio-Rad Laboratories Inc.
  • Carl Zeiss Meditec AG
  • DYSIS Medical Ltd.
  • Newport Corp.
  • Olympus Corp.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules and Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Becton, Dickinson & Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Carl Ziess Meditec AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Hamamatsu Photonics K.K. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Thermo Fisher Scientific, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Olympus Corp. Overview Financial Analysis SWOT Analysis Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Biophotonics Market by Technology
5.1.1. In-Vitro
5.1.2. In-Vivo
5.2. Global Biophotonics Market by Application
5.2.1. Microscopy
5.2.2. Biosensors
5.2.3. Imaging
5.2.4. Other Applications (Spectro-Molecular, Light Application)
5.3. Global Biophotonics Market by End-Use
5.3.1. Medical Diagnostic
5.3.2. Medical Therapeutic
5.3.3. Medical Monitoring
5.3.4. Others (Non-Medical such as Agriculture)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Agilent Technologies, Inc.
7.2. Andor Technology Ltd.
7.3. Becton, Dickinson & Co.
7.4. Biophotonic Solutions, Inc.
7.5. Bio-Rad Laboratories Inc.
7.6. Bruker Corp.
7.7. Carl Zeiss Meditec AG
7.8. Clearbridge BioPhotonics Pte Ltd
7.9. Coherent, Inc.
7.10. DYSIS Medical Ltd.
7.11. Hamamatsu Photonics, K. K.
7.12. Lumentum Operations LLC
7.13. Newport Corp.
7.14. Novanta Inc.
7.15. Olympus Corp.
7.16. Oxford Instruments PLC
7.17. PerkinElmer, Inc.
7.18. Thermo Fisher Scientific, Inc.
7.19. Zecotek Photonics, Inc.
7.20. Zenalux Biomedical, Inc.
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • Agilent Technologies, Inc.
  • Andor Technology Ltd.
  • Becton, Dickinson & Co.
  • Biophotonic Solutions, Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Carl Zeiss Meditec AG
  • Clearbridge BioPhotonics Pte Ltd
  • Coherent, Inc.
  • DYSIS Medical Ltd.
  • Hamamatsu Photonics, K. K.
  • Lumentum Operations LLC
  • Newport Corp.
  • Novanta Inc.
  • Olympus Corp.
  • Oxford Instruments PLC
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Zecotek Photonics, Inc.
  • Zenalux Biomedical, Inc.
Note: Product cover images may vary from those shown